Charted Scientific
Charted Scientific
  • Home
  • Technology
  • Immunoassays
  • Cytometry
  • About Us
  • More
    • Home
    • Technology
    • Immunoassays
    • Cytometry
    • About Us
  • Home
  • Technology
  • Immunoassays
  • Cytometry
  • About Us

Fast, sensitive multiplexing

SOFI offers a refreshing change to the bead-based immunoassay. The microsphere-based multiplexed immunoassay format offers high sensitivity and good flexibility for development of new assays. While this assay format has seen widespread adoption in many life science research applications, market penetration in high-throughput labs is limited by low assay read speed, high reagent costs, and inadequate instrument reliability. 


SOFI offers higher sensitivity than traditional bead-based assay platforms combined with multiplexing up to 50 target analytes. Our scanning technology delivers read times of less than 15 minutes for 96-well plates, and the elimination of read failures associated with sample handling that are prevalent in flow cytometer-based assay readers.


SOFI is an open platform, meaning that you have instant access to many of the commercially-available assay kits already on the market.

image1035
BD CBA

Human Inflammatory Panel

Running CBA multiplexed assays on SOFI offers flexibility, speed and sensitivity on a no-hassle benchtop platform.


  • Demonstrates multiplexed quantification of 6 analytes (IL-6, IL-8, IL-10, IL1ß, TNF- α , and IL-12p70).
  • Exhibits 10x better sensitivity for IL-6 and IL-10 using BD's enhanced sensitivity reagents.

Download App Note

Copyright © 2018 Charted Scientific, Inc. - All Rights Reserved.

info@chartedscientific.com